Human Papillomavirus Vaccines: WHO Position Paper, December 2022

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning the revised recommendations from WHO on the use of HPV vaccines.

HOW YOU CAN USE THIS MATERIAL:

Immunisation programme managers and decision-makers can use these updated guidelines to optimize their national HPV schedule and improve access and coverage of the vaccine.

OVERVIEW:

WHO has updated its recommendations for the human papillomavirus (HPV) vaccine in a position paper published in December 2022. The position paper states that a single-dose schedule, referred to as an alternative, off-label single–dose schedule, can provide a comparable efficacy and durability of protection to a two-dose regimen. The optimization of the HPV schedule is expected to improve access to the vaccine, offering countries the opportunity to expand the number of girls who can be vaccinated and alleviating the burden of the often complicated and costly follow-up required to complete the vaccination series. It’s vital that countries strengthen their HPV vaccination programmes, expedite implementation, and reverse the declines in coverage experienced during the Covid-19 pandemic.

You May Also Like

Linked Brief: New vaccine introduction in middle income countries: HPV demand generation and vaccine acceptance strategies – Key takeaways from Linked’s workshop held on October 22-23rd, 2024

The Linked Immunisation Action Network welcomed immunisation practitioners from six middle-income countries (MICs) along with global and regional technical experts, for a workshop focused on “New Vaccines Introduction in Middle Income Countries: HPV demand generation and vaccine acceptance strategies”. Held in Istanbul, Turkey, on 22-23 October 2024, the objective of this workshop was to facilitate … Read More

Download
File size: 319.55K

Linked Workshop: New vaccine introduction in Middle Income Countries: HPV Demand generation and vaccine acceptance strategies

Linked convened country representatives and partners from Cuba, Kosovo, Mongolia, Philippines, Tunisia, and Viet Nam, to discuss challenges to build trust, acceptance, and uptake of the HPV vaccine, as well as tools and strategies to support countries to overcome these challenges. Explore country experiences in the workshop materials below. Country Posters Cuba Kosovo Mongolia Philippines … Read More

Linked Webinar: One-dose HPV vaccination: Evidence, lessons learned and implementation strategies, with experiences from Guyana and Estonia

Choosing or switching to a single dose HPV vaccination can simplify delivery and lower program costs. It can also help reduce the potential for supply shortages and loss to follow-up. Linked held a virtual learning session to aid countries who are in the initial stages of introducing the HPV vaccine or considering a switch, strengthening … Read More